CELLFORGE
Live / Applied — New application — not yet assigned to an examiner (as of 30 Mar 2026)
What this means for you
Not registered yet, but its 30 Mar 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99734085
- Mark type
- Stylized text
- Filed
- 30 Mar 2026
- Attorney of record
- Jeffrey P. Dunning
Goods and services
- Class 001 — Chemicals: Biological tissue, namely, cells, organoids and tissue models for use in scientific and medical research
- Class 009 — Scientific and electric apparatus: Downloadable artificial intelligence powered software for cell therapy manufacturing, human tissue design, analyzing cellular state data, generating digital cell atlases, discovering and optimizing cell culture protocols, predicting cell differentiation outcomes, optimizing biomanufacturing workflows, collecting high-resolution cell telemetry data, and generating digital cell state references; multi-purpose cell culture device for processing organoids, stem cells, and primary cells for scientific and research use; computer hardware and recorded software systems for use in drug discovery, drug development, isolation and cultivation of human tissues and cells, cell therapy manufacturing and human tissue design
- Class 040 — Treatment of materials: Custom manufacturing of cells, organoids and tissue models for use in scientific and medical research
- Class 042 — Scientific and technological services: Platform as a service (PAAS) featuring software for cell therapy manufacturing, human tissue design, analyzing cellular state data, generating digital cell atlases, discovering and optimizing cell culture protocols, predicting cell differentiation outcomes, optimizing biomanufacturing workflows, collecting high-resolution cell telemetry data, and generating digital cell state references; Software as a service (SaaS) featuring machine learning and reinforcement learning frameworks for closed-loop control of biomanufacturing systems; cloud-based software services for integrating laboratory instruments and automating cell therapy production workflows; scientific research in the fields of drug discovery, drug development, isolation and cultivation of human tissues and cells, cell therapy manufacturing and human tissue design; tissue characterization, namely, analysis of biological tissue properties using imaging processes; software orchestration services in the field of cell therapy manufacturing technology; scientific laboratory services relating to the isolation and cultivation of human tissues and cells; engineering services in the field of human tissue design and tissue engineering
Owner
- iOrganBio, Inc., Chapel Hil, NC, US
Prosecution history
- 30 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 30 Mar 2026 — NEW APPLICATION ENTERED